8-K: iCoreConnect Faces Nasdaq Listing Compliance Issues Following Director Resignation

iCoreConnect Inc. reports non-compliance with Nasdaq listing rules due to a board and audit committee vacancy following Yvonne Hyland's resignation.

Summary

• iCoreConnect Inc. has notified Nasdaq that it is not in compliance with certain listing rules.
• The non-compliance stems from a vacancy on the Board of Directors and Audit Committee due to Yvonne Hyland's resignation, effective March 5, 2025.
• This affects the majority independent director requirement and the audit committee requirement under Nasdaq Listing Rules 5605(b)(1) and 5605(c)(2)(A).
• iCoreConnect has a cure period until the earlier of the next annual shareholders meeting or March 5, 2026, but if the next annual shareholders meeting is held before September 1, 2025, then the Company must evidence compliance no later than September 1, 2025.
• The company intends to appoint one or more independent directors to fill the vacancy during the cure period.
• Yvonne Hyland's resignation was not due to any disagreement with the company.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to the non-compliance with Nasdaq listing rules, but the company has a plan to address the issue.

Positives

• The company has a cure period to regain compliance with Nasdaq listing rules.
• The company intends to appoint new independent directors to address the vacancy.
• Yvonne Hyland's resignation was not due to any disagreement with the company.

Negatives

• iCoreConnect is currently not in compliance with Nasdaq listing rules regarding independent directors and audit committee composition.
• The resignation of Yvonne Hyland has created a vacancy on the Board and Audit Committee.

Risks

• Failure to appoint new independent directors within the cure period could lead to delisting from Nasdaq.
• The company's reputation could be negatively impacted by the non-compliance.

Future Outlook

The company intends to elect one or more independent directors to serve as a member of the Board and the Audit Committee during the cure period.

Industry Context

Many companies face challenges in maintaining compliance with listing requirements, especially regarding board composition. This announcement highlights the importance of succession planning and proactive board management.

Management Changes

Stakeholder Impact

• Shareholders may be concerned about the company's non-compliance with Nasdaq listing rules.
• Employees may experience uncertainty due to the board vacancy.

Next Steps

• iCoreConnect needs to appoint one or more independent directors to the Board and Audit Committee.
• The company must demonstrate compliance with Nasdaq listing rules by the earlier of the next annual shareholders meeting or March 5, 2026 (or potentially September 1, 2025).

Key Dates